Results 71 to 80 of about 641 (170)

Decoding (digital) histopathology: The building blocks for computational researchers. [PDF]

PLOS Digit Health
Dammak S, Caputo A, Montezuma D, L'Imperio V, Oliveira SP, European Society of Digital and Integrative Pathology (ESDIP).   +5 more
europepmc   +1 more source

Recent Advanced Diagnostic Aids in Orthodontics. [PDF]

Cureus, 2022
Baxi S, Shadani K, Kesri R, Ukey A, Joshi C, Hardiya H.   +5 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

From Knowledge to Action: Next Steps for the Natural Science Collections Community. [PDF]

Bioscience
Ellwood ER, Nelson G, Zimkus B, Bates J, Cook JA, Pandey J, Sessa E, Borths M, Goodwin J, Jennings D, Soltis PS.   +10 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Shortened High-dose Palliative Radiotherapy for Lung Cancer (SHiP-Rt): protocol for a single-arm, multicentre, phase II study. [PDF]

BMJ Open
Shrimali RK, Griffin E, Sturgess V, Jones M, Hiller L, Rogers J, Hamilton J, Peebles C, Jones B, Dunn J.   +9 more
europepmc   +1 more source

Adverse events in bedaquiline‐ and pretomanid‐based regimens for drug‐resistant tuberculosis from trial, implementation and pharmacovigilance studies

British Journal of Clinical Pharmacology, EarlyView.
Abstract The availability of safety data, particularly concerning adverse events (AEs) associated with the new shorter regimen for drug‐resistant tuberculosis (TB) containing a bedaquiline–pretomanid‐based regimen, is still limited. This systematic review aims to provide a comprehensive and updated analysis of AEs related to this new regimen by ...
Nisa Maria, Annisa Lazuardi Larasati, Indri Yuliani Hamdani, Jin‐Gun Cho, Jan‐Willem C. Alffenaar   +4 more
wiley   +1 more source

Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working Group. [PDF]

Eur Radiol
Dias AB, Barentsz J, Allen C, Baroni RH, Falińska H, Gaudiano C, Girometti R, Gupta RT, Jäderling F, Junker D, Kukuk GM, Moreira ASL, Løgager V, Puech P, Purysko AS, Uhlig J, Ursprung S, Villeirs G, Richenberg J, Giganti F, ESUR Prostate MRI Working Group.   +20 more
europepmc   +1 more source

Contraindicated drug–drug interactions and associated adverse drug reactions in an observational cohort study of 4543 paediatric hospitalized patients

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background and Purpose Drug–drug interactions (DDIs) are associated with an increased risk of adverse drug reactions (ADRs). Hospitalized children are particularly vulnerable to DDIs and ADRs due to polypharmacy, frequent use of unlicensed or off‐label medications, and dosing regimens often extrapolated from adult data.
Emilie Laval, Sylvain Goutelle, Inesse Boussaha, Xavier Dode, Yanis Mimouni, Kim An Nguyen, Behrouz Kassai   +6 more
wiley   +1 more source

Experimental data collected during quasi-static cyclic loading of mass timber lateral force-resisting system tested in a three-story building structure. [PDF]

Data Brief
Thielsen NT, Sinha A, Barbosa AR, Simpson BG, Cheney D.   +4 more
europepmc   +1 more source